search results for 
Logo

Fresenius SE & Co. KGaA
Consolidated statement of changes in equity


    Ordinary shares Preference shares Subscribed Capital Reserves        
  Note Number of shares in thousand Amount
€ in thousands
Number of shares in thousand Amount
€ in thousands
Amount
€ in thousands
Amount € in millions Capital reserve € in millions Other reserves € in millions Accumulated other comprehensive income (loss)
€ in millions
Total Fresenius SE & Co. KGaA shareholders’ equity
€ in millions
Noncontrolling interest not subject to put provisions
€ in millions
Total shareholders’ equity
€ in millions
The following notes are an integral part of the consolidated financial statements.
As of December 31, 2009   80,658 80,658 80,658 80,658 161,316 161 2,035 2,183 -145 4,234 3,257 7,491
Proceeds from the exercise of stock options 34 567 567 567 567 1,134 1 37     38 83 121
Compensation expense related to stock options 34             19     19 14 33
Dividends paid 27               -122   -122 -172 -294
Purchase of noncontrolling interest not subject to put provisions 26                   0 35 35
Change in fair value of noncontrolling interest subject to put provisions 26             -6     -6 -27 -33
Comprehensive income (loss)                          
Net income                 622   622 561 1,183
Other comprehensive income (loss)                          
Cash flow hedges 28, 30                 -12 -12 0 -12
Foreign currency translation 28, 30                 230 230 128 358
Actuarial losses on defined benefit pension plans 25, 28                 -38 -38 0 -38
Comprehensive income                 622 180 802 689 1,491
As of December 31, 2010   81,225 81,225 81,225 81,225 162,450 162 2,085 2,683 35 4,965 3,879 8,844
Conversion of the preference shares into ordinary shares 1 81,225 81,225 -81,225 -81,225 0 0       0 0 0
Proceeds from the exercise of stock options 34 787 787     787 1 30     31 68 99
Compensation expense related to stock options 34             20     20 15 35
Dividends paid 27               -140   -140 -192 -332
Purchase of noncontrolling interest not subject to put provisions 26                   0 42 42
Maturity of Mandatory Exchangeable Bonds 23               467   467 298 765
Purchase of ordinary shares of Fresenius Medical Care AG & Co. KGaA 2, 26               -42   -42 -28 -70
Change in fair value of noncontrolling interest subject to put provisions 26             -20     -20 -47 -67
Comprehensive income (loss)                          
Net income                 690   690 605 1,295
Other comprehensive income (loss)                          
Cash flow hedges 28, 30                 -54 -54 0 -54
Foreign currency translation 28, 30                 95 95 -34 61
Actuarial losses on defined benefit pension plans 25, 28                 -41 -41 0 -41
Comprehensive income                 690 - 690 571 1,261
As of December 31, 2011   163,237 163,237 0 0 163,237 163 2,115 3,658 35 5,971 4,606 10,577

    Ordinary shares Preference shares Subscribed Capital Reserves        
  Note Number of shares in thousand Amount
€ in thousands
Number of shares in thousand Amount
€ in thousands
Amount
€ in thousands
Amount € in millions Capital reserve € in millions Other reserves € in millions Accumulated other comprehensive income (loss)
€ in millions
Total Fresenius SE & Co. KGaA shareholders’ equity
€ in millions
Noncontrolling interest not subject to put provisions
€ in millions
Total shareholders’ equity
€ in millions
The following notes are an integral part of the consolidated financial statements.
As of December 31, 2009   80,658 80,658 80,658 80,658 161,316 161 2,035 2,183 -145 4,234 3,257 7,491
Proceeds from the exercise of stock options 34 567 567 567 567 1,134 1 37     38 83 121
Compensation expense related to stock options 34             19     19 14 33
Dividends paid 27               -122   -122 -172 -294
Purchase of noncontrolling interest not subject to put provisions 26                   0 35 35
Change in fair value of noncontrolling interest subject to put provisions 26             -6     -6 -27 -33
Comprehensive income (loss)                          
Net income                 622   622 561 1,183
Other comprehensive income (loss)                          
Cash flow hedges 28, 30                 -12 -12 0 -12
Foreign currency translation 28, 30                 230 230 128 358
Actuarial losses on defined benefit pension plans 25, 28                 -38 -38 0 -38
Comprehensive income                 622 180 802 689 1,491
As of December 31, 2010   81,225 81,225 81,225 81,225 162,450 162 2,085 2,683 35 4,965 3,879 8,844
Conversion of the preference shares into ordinary shares 1 81,225 81,225 -81,225 -81,225 0 0       0 0 0
Proceeds from the exercise of stock options 34 787 787     787 1 30     31 68 99
Compensation expense related to stock options 34             20     20 15 35
Dividends paid 27               -140   -140 -192 -332
Purchase of noncontrolling interest not subject to put provisions 26                   0 42 42
Maturity of Mandatory Exchangeable Bonds 23               467   467 298 765
Purchase of ordinary shares of Fresenius Medical Care AG & Co. KGaA 2, 26               -42   -42 -28 -70
Change in fair value of noncontrolling interest subject to put provisions 26             -20     -20 -47 -67
Comprehensive income (loss)                          
Net income                 690   690 605 1,295
Other comprehensive income (loss)                          
Cash flow hedges 28, 30                 -54 -54 0 -54
Foreign currency translation 28, 30                 95 95 -34 61
Actuarial losses on defined benefit pension plans 25, 28                 -41 -41 0 -41
Comprehensive income                 690 - 690 571 1,261
As of December 31, 2011   163,237 163,237 0 0 163,237 163 2,115 3,658 35 5,971 4,606 10,577

Continue reading:
Consolidated segment reporting